The 3rd annual Immuno-Oncology 360° event is taking place February 1-3, 2017 in NYC and designed by lead Advisors Dr Axel Hoos (GSK) and Dr James Gulley (NCI).

The program provides a 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated.

Read more about Immuno-Oncology 360 2017 here